| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AGILE THERAPEUTICS INC | Director | Common Stock | 0 | $0 | $1.52 | 26 Aug 2024 | Direct |
| VYNE Therapeutics Inc. | Director | Stock Option (right to buy) | 20,000 | 12 Dec 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| VYNE | VYNE Therapeutics Inc. | 12 Dec 2025 | 1 | $0 | 4 | Director | 15 Dec 2025, 16:15 |
| VYNE | VYNE Therapeutics Inc. | 12 Dec 2024 | 1 | $0 | 4 | Director | 13 Dec 2024, 16:15 |
| AGRX | AGILE THERAPEUTICS INC | 26 Aug 2024 | 1 | -$1,479 | 4 | Director | 26 Aug 2024, 17:35 |
| VYNE | VYNE Therapeutics Inc. | 01 Jan 2024 | 1 | $0 | 4 | Director | 03 Jan 2024, 17:09 |
| VYNE | VYNE Therapeutics Inc. | 13 Dec 2023 | 1 | $0 | 4 | Director | 15 Dec 2023, 17:01 |
| AGRX | AGILE THERAPEUTICS INC | 08 Jun 2023 | 2 | $0 | 4 | Director | 09 Jun 2023, 17:08 |
| VYNE | VYNE Therapeutics Inc. | 10 Aug 2022 | 1 | $0 | 4 | Director | 12 Aug 2022, 17:10 |
| AGRX | AGILE THERAPEUTICS INC | 09 Jun 2022 | 2 | $0 | 4 | Director | 10 Jun 2022, 16:49 |
| VYNE | VYNE Therapeutics Inc. | 19 Jul 2021 | 1 | $0 | 4 | Director | 20 Jul 2021, 17:04 |
| AGRX | AGILE THERAPEUTICS INC | 08 Jun 2021 | 2 | $0 | 4 | Director | 10 Jun 2021, 19:11 |